OTC · Drug Manufacturers - Specialty & Generic

China Health Industries Holdings, Inc. (CHHE) Stock

$0.00 OTC: CHHE Healthcare

Operating through its various subsidiaries, China Health Industries Holdings, Inc. specializes in the production and distribution of a comprehensive array of health-oriented goods.

Valuation

MetricValue
Price$0.00
Market Cap$6554
P/E Ratio-0.02
P/B Ratio0.00
P/S Ratio0.07
EPS (TTM)$-0.02
52-Week High$0.22
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-6.89%
ROA-3.28%
ROCE-4.71%
Gross Margin-5.33%
Operating Margin-163512.65%
Net Margin0.00%
Debt/Equity0.13
Current Ratio0.04

Annual Financials (USD)

Metric20192020202120222023
Revenue$9.0M$10.0M$6.0M$0$0
Operating Profit$5.0M$5.0M$2.0M$-2.0M$-2.0M
Net Profit$3.0M$4.0M$1.0M$0$0
EPS$0.05$0.05$0.02$-0.01$-0.01
Op Margin49.2%49.3%28.7%-617228.5%-1651.7%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$46.0M$48.0M$54.0M$51.0M$45.0M
Total Liabilities$9.0M$9.0M$9.0M$8.0M$6.0M
Cash$36.0M$36.0M$44.0M$45.0M$0
Borrowings$7.0M$7.0M$8.0M$7.0M$5.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$5.0M$2.0M$6.0M$2.0M$-42.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$3.0M$1.0M$8.0M$0$-45.0M
Free Cash Flow$5.0M$2.0M$6.0M$2.0M$-42.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-4.42
FCF Yield-644987.76%
Quick Ratio6.85
Interest Coverage-3194.11
Return 1Y-99.95%
Return 3Y-99.93%
Return 5Y—

Ownership

Insiders Held31.29%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BQSTBioQuest Corp. $0.07 +0.00% -2.18 $758023 0.00%
ECGSEco-Growth Strategies Inc. $0.04 -23.21% -2.54 $2.45M 0.00%
LUFFFHerbal Dispatch Inc. $0.03 +26.73% -1.57 $8.55M 0.00%
MCUJFMedicure Inc. $0.67 -16.72% -1.61 $7.04M 0.00%
MYCOFNoveris Health Sciences Inc. $0.80 +0.00% -70.00 $46.84M 0.00%

About China Health Industries Holdings, Inc.

Operating through its various subsidiaries, China Health Industries Holdings, Inc. specializes in the production and distribution of a comprehensive array of health-oriented goods. Its product portfolio features numerous hemp-derived items, including hemp oil, protein powders, polypeptides, and a selection of skincare solutions like essence repair lotions, revitalizing essences, anti-aging brightening eye creams, and nourishing creams designed to combat signs of aging. The company also supplies dietary supplements, such as the QunLe brand's Sailuozhi soft capsules, which combine frog oil, soybean isoflavone, procyanidine, and vitamin E to help reduce freckles and enhance skin moisture. Another key offering is the Kindlink brand's propolis and black ant capsules, formulated with propolis, black ant, acanthopanax, and astragalus root. Beyond these, China Health Industries provides a range of health products addressing specific concerns like acne treatment, relief from eye strain, boosting bone density, improving memory, combating nutritional anemia and chloasma, promoting digestive health and lead detoxification, bolstering immunity, alleviating physical fatigue, and diminishing chloasma, alongside essential iron and multi-vitamin and mineral supplements. Additionally, the firm is involved in the manufacturing and sale of various medical drugs. The distribution of its extensive product line is primarily managed through a network of sales agents. China Health Industries Holdings, Inc. maintains its base of operations in Harbin City, People's Republic of China.

China Health Industries Holdings, Inc. (CHHE) stock trades at $0.00 with a market capitalization of $6554. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of 0.00, price-to-sales of 0.07. Over the past 52 weeks the stock has ranged between $0.00 and $0.22, and currently trades 100.0% below its 52-week high.

On profitability, China Health Industries Holdings, Inc. generates a return on equity (ROE) of -6.89%, return on capital employed of -4.71%, an operating margin of -163512.65%, a net profit margin of 0.00%.

Official website: www.candidiasis-stichting.nl

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides